Human medicines European public assessment report (EPAR): Hemlibra, emicizumab, Date of authorisation: 23/02/2018, Revision: 21, Status: Authorised
الصحة واللياقة البدنية
Human medicines European public assessment report (EPAR): Hemlibra, emicizumab, Date of authorisation: 23/02/2018, Revision: 21, Status: Authorised
Human medicines European public assessment report (EPAR): Hemlibra, emicizumab, Date of authorisation: 23/02/2018, Revision: 21, Status: Authorised
AAdmin
٢٧ أكتوبر ٢٠٢٦
1 دقيقة قراءة
